CD68 and melanoma: The combi-ICI-treated, melanoma-burdened mice treated with vehicle, as well as the melanoma-bearing mice receiving combi-ICI, showed significant increases (P’s < 0.0001) in CD68-IBA1 dual immunoreactivity in the hippocampal dentate gyrus (DG), indicating microglial activation (Fig. 4B-C).